Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Current Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
Total Current Liabilities ₹262 Cr₹216 Cr₹194 Cr₹98 Cr₹72 Cr

What is the latest Total Current Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Total Current Liabilities ratio of NATH BIOGENES (INDIA) is ₹262 Cr based on Mar2024 Consolidated results.
Year Total Current Liabilities
Mar2024₹262 Cr
Mar2023₹216 Cr
Mar2022₹194 Cr
Mar2013₹98 Cr
Mar2012₹72 Cr

How is Total Current Liabilities of NATH BIOGENES (INDIA) Trending?

Years Total Current Liabilities % Change
Mar2024 ₹262 Cr
21.26
Mar2023 ₹216 Cr
11.40
Mar2022 ₹194 Cr
98.02
Mar2013 ₹98 Cr
36.20
Mar2012 ₹72 Cr -

Compare Total Current Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹376.3 Cr 9.4% 6.2% -4.6% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹16,842.9 Cr -5.1% -12.2% 71.1% Stock Analytics
KAVERI SEED COMPANY ₹4,714.1 Cr 0.7% 1.5% 47.5% Stock Analytics
VENKYS (INDIA) ₹2,471.9 Cr 2.5% -2.7% -13.1% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,705.8 Cr 12.7% -1.8% -21.8% Stock Analytics
TIERRA AGROTECH ₹416.9 Cr -0% 0.8% -34.1% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

9.4%

6.2%

-4.6%

SENSEX

1.1%

1.1%

22.2%


You may also like the below Video Courses